GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » EV-to-FCF

Psyence Biomedical (Psyence Biomedical) EV-to-FCF : (As of May. 13, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Psyence Biomedical's Enterprise Value is $13.52 Mil. Psyence Biomedical does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2023. Therefore, GuruFocus does not calculate Psyence Biomedical's EV-to-FCF at this moment.

The historical rank and industry rank for Psyence Biomedical's EV-to-FCF or its related term are showing as below:

PBM' s EV-to-FCF Range Over the Past 10 Years
Min: -20.05   Med: 0   Max: 0
Current: -9.55

PBM's EV-to-FCF is ranked worse than
100% of 389 companies
in the Biotechnology industry
Industry Median: 6.49 vs PBM: -9.55

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-13), Psyence Biomedical's stock price is $0.9649. Psyence Biomedical does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023. Therefore, GuruFocus does not calculate Psyence Biomedical's PE Ratio at this moment.


Psyence Biomedical EV-to-FCF Historical Data

The historical data trend for Psyence Biomedical's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical EV-to-FCF Chart

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23
EV-to-FCF
- - -

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Mar23
EV-to-FCF - - -

Competitive Comparison of Psyence Biomedical's EV-to-FCF

For the Biotechnology subindustry, Psyence Biomedical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyence Biomedical's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's EV-to-FCF falls into.



Psyence Biomedical EV-to-FCF Calculation

Psyence Biomedical's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=13.524/
=


Psyence Biomedical  (NAS:PBM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Psyence Biomedical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.9649/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Psyence Biomedical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Biomedical (Psyence Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines